Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Colombo N, Sessa C, Du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019;30(5):672–705.
   PubMed Web of Science ®Google Scholar
• Du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzinom (AGO-OVAR) and the groupe d‘Investigateurs nationaux pour les etudes des cancers de l‘Ovaire (GINECO). cancer. Cancer. 2009;115(6):1234–1244.
   PubMed Web of Science ®Google Scholar
• Stuart GC, Kitchener H, Bacon M, et al. 2010 Gynecologic cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the fourth ovarian cancer consensus conference. Int J Gynecol Cancer. 2011;21(4):750–755.
   PubMed Web of Science ®Google Scholar
• Reuss A, Du Bois A, Harter P, et al. TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7). Int J Gynecol Cancer. 2019;29(8):1327–1331.
   PubMed Web of Science ®Google Scholar
• Tsili AC, Naka C, Argyropoulou MI. Multidetector computed tomography in diagnosing peritoneal metastases in ovarian carcinoma. Acta Radiol. 2021;62(12):1696–1706.
   PubMed Web of Science ®Google Scholar
• Caramella C, Pottier E, Borget I, et al. Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis. Eur J Cancer. 2013;49(18):3798–3805.
   PubMed Web of Science ®Google Scholar
• Luger AK, Steinkohl F, Aigner F, et al. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer. Acta Obstet Gynecol Scand. 2020;99(8):1092–1099.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374.
   PubMedGoogle Scholar
• Kolev V, Mironov S, Mironov O, et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20(6):979–984.
   PubMed Web of Science ®Google Scholar
• Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014;134(3):455–461.
   PubMed Web of Science ®Google Scholar
• Mert I, Kumar A, Sheedy SP, et al. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: implications for survival. Gynecol Oncol. 2018;148(1):68–73.
   PubMed Web of Science ®Google Scholar
• Prader S, Vollmar N, Du Bois A, et al. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer. Gynecol Oncol. 2019;152(1):76–81.
   PubMed Web of Science ®Google Scholar
• Forstner R, Sala E, Kinkel K, et al. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol. 2010;20(12):2773–2780.
   PubMed Web of Science ®Google Scholar
• Prader S, Harter P, Grimm C, et al. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer. Gynecol Oncol. 2016;141(2):271–275.
   PubMed Web of Science ®Google Scholar
• Salehi S, Mohammar R, Suzuki C, et al. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging. Acta Oncol. 2018;57(6):820–824.
   PubMed Web of Science ®Google Scholar
• Sartor H, Bjurberg M, Asp M, et al. Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters. J Ovarian Res. 2020;13(1):26.
   PubMed Web of Science ®Google Scholar
• Harter P, Sehouli J, Lorusso D, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822–832.
   PubMed Web of Science ®Google Scholar
• Hjerpe E, Staf C, Dahm-Kähler P, et al. Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a swedish gynecologic cancer group (SweGCG) study. Acta Oncol. 2018;57(3):331–337.
   PubMed Web of Science ®Google Scholar
• Abu-Hijleh MF, Habbal OA, Moqattash ST. The role of the diaphragm in lymphatic absorption from the peritoneal cavity. J Anat. 1995;186(Pt 3):453–67.
   PubMed Web of Science ®Google Scholar
• Holloway BJ, Gore ME, A'Hern RP, et al. The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol. 1997;52(9):692–697.
   PubMed Web of Science ®Google Scholar
• Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 2017;145(1):27–31.
   PubMed Web of Science ®Google Scholar
• Zwakman N, van de Laar R, Van Gorp T, et al. Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer. J Gynecol Oncol. 2017;28(1):e7.
   PubMed Web of Science ®Google Scholar
• Piatek S, Panek G, Lewandowski Z, et al. Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer. Sci Rep. 2021;11(1):18190.
   PubMed Web of Science ®Google Scholar